neueste Dateien - Age-Related Macular Degeneration - Dry
|
Reticular pseudodrusen101 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen108 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen104 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen93 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen95 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen88 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen107 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen105 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen98 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen106 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen90 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen98 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen94 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen99 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen99 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen109 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen104 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen92 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen92 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen87 x angesehen23. Februar 2025
|
|
Reticular pseudodrusen89 x angesehen23. Februar 2025
|
|
54 year old female with a lot of drusen88 x angesehenVA 20/12 OD, 20/16 OS - no symptoms21. Dezember 2024
|
|
54 year old female with a lot of drusen82 x angesehenVA 20/12 OD, 20/16 OS - no symptoms21. Dezember 2024
|
|
54 year old female with a lot of drusen87 x angesehenVA 20/12 OD, 20/16 OS - no symptoms21. Dezember 2024
|
|
54 year old female with a lot of drusen82 x angesehenVA 20/12 OD, 20/16 OS - no symptoms21. Dezember 2024
|
|
54 year old female with a lot of drusen102 x angesehenVA 20/12 OD, 20/16 OS - no symptoms21. Dezember 2024
|
|
54 year old female with a lot of drusen98 x angesehenVA 20/12 OD, 20/16 OS - no symptoms21. Dezember 2024
|
|
54 year old female with a lot of drusen91 x angesehenVA 20/12 OD, 20/16 OS - no symptoms21. Dezember 2024
|
|
54 year old female with a lot of drusen90 x angesehenVA 20/12 OD, 20/16 OS - no symptoms21. Dezember 2024
|
|
Large Hyper-reflective drusen in age-related macular degeneration139 x angesehen69 year old healthy woman with 20/20 vision and no visual complaints22. September 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration142 x angesehen69 year old healthy woman with 20/20 vision and no visual complaints22. September 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration131 x angesehen69 year old healthy woman with 20/20 vision and no visual complaints22. September 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration124 x angesehen69 year old healthy woman with 20/20 vision and no visual complaints22. September 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration144 x angesehen69 year old healthy woman with 20/20 vision and no visual complaints22. September 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration144 x angesehen69 year old healthy woman with 20/20 vision and no visual complaints22. September 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration136 x angesehen69 year old healthy woman with 20/20 vision and no visual complaints22. September 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration123 x angesehen69 year old healthy woman with 20/20 vision and no visual complaints22. September 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration135 x angesehen69 year old healthy woman with 20/20 vision and no visual complaints22. September 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion121 x angesehen80 year old female with 20/50 vision in both eyes. Mild blurring17. September 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion113 x angesehen80 year old female with 20/50 vision in both eyes. Mild blurring17. September 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion104 x angesehen80 year old female with 20/50 vision in both eyes. Mild blurring17. September 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion102 x angesehen80 year old female with 20/50 vision in both eyes. Mild blurring17. September 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion109 x angesehen80 year old female with 20/50 vision in both eyes. Mild blurring17. September 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion130 x angesehen80 year old female with 20/50 vision in both eyes. Mild blurring17. September 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion128 x angesehen80 year old female with 20/50 vision in both eyes. Mild blurring17. September 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion111 x angesehen80 year old female with 20/50 vision in both eyes. Mild blurring17. September 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion130 x angesehen80 year old female with 20/50 vision in both eyes. Mild blurring17. September 2023
|
|
Optic Disc Melanocytoma - Atypical249 x angesehen45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17. August 2022
|
|
Optic Disc Melanocytoma - Atypical221 x angesehen45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17. August 2022
|
|
Optic Disc Melanocytoma - Atypical219 x angesehen45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17. August 2022
|
|
Optic Disc Melanocytoma - Atypical221 x angesehen45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17. August 2022
|
|
Optic Disc Melanocytoma - Atypical217 x angesehen45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17. August 2022
|
|
Optic Disc Melanocytoma - Atypical225 x angesehen45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17. August 2022
|
|
Optic Disc Melanocytoma - Atypical222 x angesehen45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17. August 2022
|
|
Optic Disc Melanocytoma - Atypical224 x angesehen45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17. August 2022
|
|
Optic Disc Melanocytoma - Atypical237 x angesehen45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17. August 2022
|
|
Optic Disc Melanocytoma - Atypical229 x angesehen45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17. August 2022
|
|
Optic Disc Melanocytoma - Atypical253 x angesehen45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17. August 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4234 x angesehen65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17. August 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4222 x angesehen65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17. August 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4223 x angesehen65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17. August 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4230 x angesehen65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17. August 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4219 x angesehen65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17. August 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4220 x angesehen65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17. August 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4207 x angesehen65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17. August 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4233 x angesehen65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17. August 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4205 x angesehen65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17. August 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4196 x angesehen65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17. August 2022
|
|
Soft Drusen245 x angesehen63 year old female with 20/16 vision both eyes17. Oktober 2021
|
|
Soft Drusen262 x angesehen63 year old female with 20/16 vision both eyes17. Oktober 2021
|
|
Soft Drusen244 x angesehen63 year old female with 20/16 vision both eyes17. Oktober 2021
|
|
Soft Drusen236 x angesehen63 year old female with 20/16 vision both eyes17. Oktober 2021
|
|
Soft Drusen242 x angesehen63 year old female with 20/16 vision both eyes17. Oktober 2021
|
|
Soft Drusen278 x angesehen63 year old female with 20/16 vision both eyes17. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes257 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes233 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes243 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes249 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes254 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes249 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes273 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes257 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes250 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes286 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes269 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes235 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes258 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes245 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes223 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes252 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes243 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes267 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes266 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes268 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes220 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes239 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes264 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes260 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes259 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetes283 x angesehen79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16. Oktober 2021
|
|
| 582 Dateien auf 6 Seite(n) |
1 |
 |
|
|
|
